Xin Guo

Dr. Guo is VP of Bioinformatics at Apostle. Before Apostle, Dr. Guo was a research scientist and research group lead at Gilead Sciences, Inc., a world-leading biotechnology company specialized in hepatitis C and HIV medication. Dr. Guo was in charge of the clinical phylogenomic program for the clinical development of Sovaldi®, a world-leading anti-HCV drug. Dr. Guo received his Ph.D. in Computer Sciences from Duke University, M.S. in Informatics from Max Planck Institute of Germany, and B.S. from Japan.

Dr. Guo has over 10 years of experience in the research and development of high-performance computing, machine learning, and artificial intelligence. Dr. Guo has extensive experience in the product development of complex big data algorithms and databases, with applications in bioinformatics and genomic big data. He has led multiple publications in AI, including an influential first-author research article in PNAS.